Services

Guides, comparisons, and research summaries that help separate the plant, the alkaloid, and the questions that deserve caution.

The working desk

Information services, not treatment or medical guidance.

01 / Orientation

A clearer starting point

Rootline is an independent resource on the differences between iboga and ibogaine, including cultural context, research, regulation, and risk.

Iboga and ibogaine are often treated as interchangeable terms, but they are not the same thing. Iboga refers to a plant associated with Central African cultural traditions. Ibogaine refers to an alkaloid associated with that plant and also studied as a distinct compound. Our core comparison of iboga and ibogaine begins with that basic distinction before moving into evidence, regulation, and safety.

These materials are designed for people seeking a careful, accessible understanding before discussing options with qualified professionals. They do not recommend treatment or use. Instead, they make room for uncertainty, context, and the practical limits of what public research can establish.

For cultural background, it matters that iboga has a history beyond laboratory language or modern treatment narratives. The broader account of the Tabernanthe iboga plant helps explain why plant, preparation, tradition, and isolated compound should not be collapsed into one category.

02 / What we make

Four ways to examine the difference

Short, practical information services for sorting terms, claims, evidence, and unanswered questions without presenting them as clinical advice.

In-depth guides

Plain-language guides set out the differences among whole-plant iboga, ibogaine, preparations, and the settings in which people may encounter these terms. Our approach to independent resource-making explains the standards behind that work.

Comparison frameworks

Comparison pages help readers identify what a claim is actually about: a plant, an isolated alkaloid, a research finding, a regulation, or a personal account. That distinction is especially useful when considering material such as an Arizona ibogaine treatment overview.

Research summaries

Research summaries describe what a study can and cannot show, including limitations in sample size, design, follow-up, and generalizability. Discussions around ibogaine and opioid addiction need that context, particularly because research interest is not the same as established medical practice.

Practical reading tools

Glossary-style explanations, question prompts, and FAQ collections help readers assess cost, testimonials, and health claims. This includes how to read an ibogaine retreat cost discussion without treating price as a signal of safety or quality.

03 / Evidence & limits

Questions before conclusions

Rootline's research summaries separate a finding from an outcome claim. A report can be interesting without being definitive; a personal narrative can be meaningful without functioning as general evidence. This is relevant when reading a first-person ibogaine trip report, where individual experience cannot answer questions about safety, efficacy, or suitability for others.

Safety language also needs precision. Ibogaine has been associated with serious cardiac concerns, and public discussion should not minimize them. The National Library of Medicine overview of long QT syndrome describes why heart-rhythm considerations can be clinically consequential, while not substituting for individualized medical assessment.

Some claims also extend to areas where uncertainty is especially important. Materials concerning ibogaine and brain injury should be read with attention to the difference between preliminary discussion, anecdote, and well-supported evidence. Rootline does not present such material as treatment guidance.

04 / FAQ

A brief service index

Are these medical or clinical services?

No. Rootline provides independent informational guides, comparisons, research summaries, glossary material, and FAQ collections. It does not diagnose, screen, recommend treatment, or offer clinical services.

Why distinguish iboga from ibogaine?

The distinction helps prevent broad claims from being transferred from a plant and its cultural context to a particular alkaloid, or in the other direction. It also supports clearer conversations about research, law, safety, and uncertainty.

Can a research summary establish that something is safe?

No. A summary can describe available evidence and its limitations, but it cannot establish individual safety. Information about ibogaine is also shaped by legal context; the U.S. Drug Enforcement Administration's drug scheduling explanation provides a general reference point for understanding controlled-substance scheduling in the United States.

Rootline / Colophon

Independent, plainspoken, and careful about what remains unknown.

For people looking to understand iboga and ibogaine before discussing options with qualified professionals, Rootline offers context—not clinical direction.